Does SARS-CoV2 vaccine exposure trigger acute-onset polyradiculopathy characterized by more common facial paralysis?

Galassi, Giuliana; Kaleci, Shaniko

Galassi, Giuliana; Kaleci, Shaniko.

Galassi G; Department of Biomedical, Metabolic Neural Sciences, University of Modena, Modena, Italy.
Kaleci S; Clinical and Experimental Medicine (CEM), Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena, Modena, Italy.

Muscle Nerve ; 66(5): E30-E31, 2022 11.

Article in English | MEDLINE | ID: covidwho-2013698

Subject(s)

COVID-19; Facial Paralysis; Guillain-Barre Syndrome; Polyradiculopathy; Vaccines; Humans; Facial Paralysis/chemically induced; RNA, Viral; COVID-19/prevention & control; SARS-CoV-2; Paralysis

Keywords

Guillain-Barré syndrome; SARS-CoV2 vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polyradiculopathy / Vaccines / Guillain-Barre Syndrome / Facial Paralysis / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Muscle Nerve Year: 2022 Document Type: Article Affiliation country: Mus.27711

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google